ONO-2020 for Healthy Participants
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial tests a new drug called ONO-2020 to see if it is safe and how it behaves in the body. It includes healthy adults, elderly people, and Japanese participants. Researchers want to understand how the drug is absorbed, processed, and eliminated from the body.
Will I have to stop taking my current medications?
Yes, you will need to stop taking any prescription or non-prescription medications, herbal remedies, or vitamin supplements at least 14 days before the study and throughout the study.
How is the drug ONO-2020 different from other treatments?
Who Is on the Research Team?
Project Leader
Principal Investigator
Ono Pharma USA Inc
Are You a Good Fit for This Trial?
Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment Part A
Single ascending doses of ONO-2020 orally under fasted and fed conditions
Treatment Part B
Multiple ascending doses of ONO-2020 orally for 14 days
Follow-up
Participants are monitored for safety and effectiveness after treatment
What Are the Treatments Tested in This Trial?
Interventions
- ONO-2020
- Placebo
Find a Clinic Near You
Who Is Running the Clinical Trial?
Ono Pharmaceutical Co. Ltd
Lead Sponsor
Shinji Takai
Ono Pharmaceutical Co. Ltd
Chief Medical Officer since 2023
MD from an unspecified institution
Gyo Sagara
Ono Pharmaceutical Co. Ltd
Chief Executive Officer since 2024
PhD in Pharmaceutical Sciences from Kyoto University